BENITEC LIMITED (ASX:BLT)
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Activity: Biotechnology, research and development.
356 Collins Street Level 16 MELBOURNE VIC 3000
Ph: (02) 9555 6986    Fax: (03) 8678 1342
Icon_lastIcon_nextIcon_previousIcon_first

Executives & Directors

Non Exec. Chairman
Non Exec. Director
Non Exec. Director
Non Exec. Director
Secretary
Please contact the ASX to change these details

Company Podcasts

Full Year Results
Wed, 22 Aug 2012
Date Payable
Thu, 22 Mar 2012
Record Date
Fri, 2 Mar 2012
Ex Div Date
Mon, 27 Feb 2012
Interim Results
Wed, 8 Feb 2012
Quarterly Production Date
Wed, 18 Jan 2012
Annual General Meeting
Thu, 17 Nov 2011
Annual General Meeting
Thu, 17 Nov 2011
Quarterly Production Date
Wed, 19 Oct 2011
Date Payable
Thu, 29 Sep 2011
PRE-CLINICAL STEM CELL THERAPY COLLABORATION Tue, 7 Feb 2012
Appendix 4C - quarterly Tue, 31 Jan 2012
Appendix 3B Fri, 27 Jan 2012
INVESTOR PRESENTATION JAN 2012 Fri, 13 Jan 2012
Appendix 3B Wed, 11 Jan 2012
CANCER VACCINE CLINICAL STUDY RESULTS Tue, 10 Jan 2012
HEPATITIS C PRE CLINICAL RESULTS Mon, 9 Jan 2012
Appendix 3B Thu, 22 Dec 2011
Appendix 3B Wed, 14 Dec 2011
Change of name to BENITEC BIOPHARMA LIMITED Mon, 28 Nov 2011

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.